
Dr. Amartya Chakraborti
Designation
Consultant - Department of Respiratory Medicine
MBBS, D.T. C. D(Diploma in Tuberculosis and Chest Diseases), D.N. B(Respiratory Medicine), DM (Pulmonary Medicine, Sleep, Critical Care Medicine)
Department
Respiratory Medicine
OPD Time
By Appointment
Request Appointment
About Doctor
Dr. Amartya Chakraborti is a skilled Consultant in the Department of Respiratory Medicine at Medica Superspecialty Hospital, Kolkata. With extensive experience in the field of pulmonary medicine, Dr. Chakraborti has previously worked in renowned institutions such as DESUN Institute, Kolkata, and the National Institute of Tuberculosis and Respiratory Diseases (NITRD), New Delhi. He served as a Registrar in intensive care from 2014-2015 and as a senior resident at NITRD, where he managed complex respiratory conditions in a high-volume setting with a dedicated respiratory ICU.
Dr. Chakraborti completed his DM fellowship at AIIMS Jodhpur, further enhancing his expertise in managing conditions like Tuberculosis, COPD, Asthma, and Interstitial Lung Diseases. He is proficient in performing invasive procedures such as fine-needle aspiration, thoracocentesis, and bronchoscopy, as well as handling patients on ECMO in critical care settings. His training in advanced diagnostic and therapeutic techniques, including EBUS, cryotherapy, and thoracoscopy, make him a trusted specialist in treating complex respiratory disorders. Additionally, Dr. Chakraborti is experienced in sleep disorder management, interpreting polysomnography reports to aid in patient care.
Areas Of Expertise
- Cryotherapy
- Sleep Disorder management
- Endobronchial Biopsy
- Transbronchial Needle Aspiration (TBNA)
- Transbronchial Lung Biopsy (TBLB)
- Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS TBNA)
- EUS
- FOB guided SEMS insertion
- Semi Rigid Thoracoscopy
Publications
- Chakraborti A, Jaiswal A, Verma PK, Singhal R. A Prospective Study of Fungal Colonization and Invasive Fungal Disease in Long-Term Mechanically Ventilated Patients in a Respiratory Intensive Care Unit. Indian J Crit Care Med. 2018;22(8):597–601.
- Patanwar S, Chakraborti A, Kumar L, Vohra V,Tayal D. Serum uric acid and clinical outcome of patients with acute exacerbation of chronic obstructive pulmonary disease.
Med J DY Patil Vidyapeeth 2020;13:658-64. - Munjal SK, Mudavath V, Chakraborti A, Arora P, Bhall M. HIV positivity in presumptive tuberculosis cases in a tertiary respiratory care institute in New Delhi, India. Med J DY Patil Vidyapeeth 2020;13:475-9.
- Singla R, Raghu B, Gupta A, Caminero JA, Sethi P, Tayal D, Chakraborty A, Jain Y, Migliori GB. Risk factors for early mortality in patients with pulmonary tuberculosis admitted to the emergency room. Pulmonology. 2020 Feb 29.
- Natarajan, S., Singla, R., Singla, N., Gupta, A., Caminero, J. A., Chakraborty, A., & Kumar, V.(2020). Treatment interruption patterns and adverse events among patients on bedaquiline containing regimen under programmatic conditions in India. Pulmonology, S2531-0437(20)30213-0.
- Bhaisare S, Gupta R, Saini J, Chakraborti A, Khot S. Sleep-Disordered Breathing in Newly Diagnosed Patients of Lung Cancer. Cureus. 2022 May 23;14(5):e25230.
- Wani AR, Kumar L, Singhal R, Chakraborti A, Khot SM. Study of spectrum of fungal isolates in the sputum of newly diagnosed pulmonary tuberculosis patients. Trop Doct.
2022 Jan;52(1):95-97. - Dutt N, Shishir S, Chauhan NK, Jalandra R, Kuwal A, Garg P, Kumar D, Vishwajeet V, Chakraborti A, Deokar K, Asfahan S, Babu A, Bajad P, Gupta N, Khurana A, Garg MK.
Mortality and Its Predictors in COVID-19 Patients With Pre-existing Interstitial Lung Disease. Cureus. 2022 Aug 7;14(8):e27759. - Kumawat A, Chakraborti A, Kumar S, Sonigra M, Bhatnagar A, Kumar A, Chopra KK. Study of factors leading to treatment delay in new sputum positive pulmonary tuberculosis patients and its impact on sputum conversion. Trop Doct. 2023 Apr;53(2):227-232.
- Agarwal M, Joshi M, Gupta M, Bharti N, Chakraborti A, Sonigra M. Role of blood urea nitrogen and serum albumin ratio in predicting severity of community acquired pneumonia (CAP). Monaldi Arch Chest Dis. 2021 Dec 3;92(3).
- Jain P , Chauhan NK , Chakraborti A , et al. Programmed cell death ligand 1 (PD-L1) expression in non-small cell lung cancer: Findings from a tertiary care institute in western part of India, Indian Journal of Tuberculosis,2023, ISSN 0019-5707, https://doi.org/10.1016/j.ijtb.2023.01.001.